XOS INC (XOS) Fundamental Analysis & Valuation

NASDAQ:XOS • US98423B3069

Current stock price

2.04 USD
+0.04 (+2%)
Last:

This XOS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. XOS Profitability Analysis

1.1 Basic Checks

  • XOS had negative earnings in the past year.
  • In the past year XOS had a positive cash flow from operations.
  • XOS had negative earnings in 4 of the past 5 years.
  • In the past 5 years XOS always reported negative operating cash flow.
XOS Yearly Net Income VS EBIT VS OCF VS FCFXOS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M

1.2 Ratios

  • XOS's Return On Assets of -46.81% is on the low side compared to the rest of the industry. XOS is outperformed by 87.02% of its industry peers.
  • XOS has a worse Return On Equity (-111.23%) than 84.73% of its industry peers.
Industry RankSector Rank
ROA -46.81%
ROE -111.23%
ROIC N/A
ROA(3y)-56.86%
ROA(5y)-56.23%
ROE(3y)-127.49%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
XOS Yearly ROA, ROE, ROICXOS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200 -300 -400

1.3 Margins

  • XOS's Gross Margin of 3.15% is on the low side compared to the rest of the industry. XOS is outperformed by 90.08% of its industry peers.
  • In the last couple of years the Gross Margin of XOS has declined.
  • XOS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 3.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-24.85%
XOS Yearly Profit, Operating, Gross MarginsXOS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. XOS Health Analysis

2.1 Basic Checks

  • XOS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • XOS has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, XOS has less shares outstanding
  • The debt/assets ratio for XOS has been reduced compared to a year ago.
XOS Yearly Shares OutstandingXOS Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
XOS Yearly Total Debt VS Total AssetsXOS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • XOS has an Altman-Z score of -4.23. This is a bad value and indicates that XOS is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of XOS (-4.23) is worse than 85.50% of its industry peers.
  • XOS has a debt to FCF ratio of 3.47. This is a good value and a sign of high solvency as XOS would need 3.47 years to pay back of all of its debts.
  • XOS has a Debt to FCF ratio of 3.47. This is in the better half of the industry: XOS outperforms 64.12% of its industry peers.
  • XOS has a Debt/Equity ratio of 0.46. This is a healthy value indicating a solid balance between debt and equity.
  • With a Debt to Equity ratio value of 0.46, XOS perfoms like the industry average, outperforming 48.85% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 3.47
Altman-Z -4.23
ROIC/WACCN/A
WACC8.77%
XOS Yearly LT Debt VS Equity VS FCFXOS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

2.3 Liquidity

  • A Current Ratio of 2.41 indicates that XOS has no problem at all paying its short term obligations.
  • XOS has a Current ratio of 2.41. This is in the better half of the industry: XOS outperforms 60.31% of its industry peers.
  • A Quick Ratio of 1.44 indicates that XOS should not have too much problems paying its short term obligations.
  • With a Quick ratio value of 1.44, XOS perfoms like the industry average, outperforming 59.54% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.41
Quick Ratio 1.44
XOS Yearly Current Assets VS Current LiabilitesXOS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. XOS Growth Analysis

3.1 Past

  • XOS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.32%, which is quite good.
  • The Revenue for XOS has decreased by -16.89% in the past year. This is quite bad
  • XOS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 117.49% yearly.
EPS 1Y (TTM)13.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20.43%
Revenue 1Y (TTM)-16.89%
Revenue growth 3Y122.95%
Revenue growth 5Y117.49%
Sales Q2Q%4.5%

3.2 Future

  • Based on estimates for the next years, XOS will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.94% on average per year.
  • The Revenue is expected to grow by 5.61% on average over the next years.
EPS Next Y44.21%
EPS Next 2Y25.74%
EPS Next 3Y18.94%
EPS Next 5YN/A
Revenue Next Year-13.88%
Revenue Next 2Y4.07%
Revenue Next 3Y6.17%
Revenue Next 5Y5.61%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
XOS Yearly Revenue VS EstimatesXOS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20M 40M 60M 80M
XOS Yearly EPS VS EstimatesXOS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -5 -10 -15

More info and screens

Find the best growth stocksShow best growing peers

2

4. XOS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for XOS. In the last year negative earnings were reported.
  • Also next year XOS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XOS Price Earnings VS Forward Price EarningsXOS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of XOS indicates a rather cheap valuation: XOS is cheaper than 99.24% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 3.69
EV/EBITDA N/A
XOS Per share dataXOS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4

4.3 Compensation for Growth

  • A more expensive valuation may be justified as XOS's earnings are expected to grow with 18.94% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.74%
EPS Next 3Y18.94%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. XOS Dividend Analysis

5.1 Amount

  • No dividends for XOS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

XOS Fundamentals: All Metrics, Ratios and Statistics

XOS INC

NASDAQ:XOS (3/13/2026, 8:04:08 PM)

2.04

+0.04 (+2%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)11-13
Earnings (Next)03-26
Inst Owners3.68%
Inst Owner Change-0.78%
Ins Owners32.88%
Ins Owner Change-1.05%
Market Cap23.11M
Revenue(TTM)52.25M
Net Income(TTM)-34.55M
Analysts76.67
Price Target6.12 (200%)
Short Float %7.19%
Short Ratio8.04
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.85%
Min EPS beat(2)15.27%
Max EPS beat(2)16.43%
EPS beat(4)2
Avg EPS beat(4)-19.5%
Min EPS beat(4)-97.18%
Max EPS beat(4)16.43%
EPS beat(8)5
Avg EPS beat(8)0.5%
EPS beat(12)7
Avg EPS beat(12)-0.23%
EPS beat(16)10
Avg EPS beat(16)3.74%
Revenue beat(2)1
Avg Revenue beat(2)16.62%
Min Revenue beat(2)-5.73%
Max Revenue beat(2)38.96%
Revenue beat(4)1
Avg Revenue beat(4)-11.41%
Min Revenue beat(4)-42.74%
Max Revenue beat(4)38.96%
Revenue beat(8)2
Avg Revenue beat(8)-11.81%
Revenue beat(12)3
Avg Revenue beat(12)-15.27%
Revenue beat(16)6
Avg Revenue beat(16)-8.3%
PT rev (1m)0%
PT rev (3m)-7.69%
EPS NQ rev (1m)0%
EPS NQ rev (3m)9.6%
EPS NY rev (1m)0%
EPS NY rev (3m)15.2%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.58%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.72%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.44
P/FCF 3.69
P/OCF 3.69
P/B 0.74
P/tB 0.74
EV/EBITDA N/A
EPS(TTM)-5.27
EYN/A
EPS(NY)-2.56
Fwd EYN/A
FCF(TTM)0.55
FCFY27.1%
OCF(TTM)0.55
OCFY27.1%
SpS4.61
BVpS2.74
TBVpS2.74
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -46.81%
ROE -111.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 3.15%
FCFM 11.99%
ROA(3y)-56.86%
ROA(5y)-56.23%
ROE(3y)-127.49%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-24.85%
F-Score4
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 3.47
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.41
Quick Ratio 1.44
Altman-Z -4.23
F-Score4
WACC8.77%
ROIC/WACCN/A
Cap/Depr(3y)244.18%
Cap/Depr(5y)306.81%
Cap/Sales(3y)14.15%
Cap/Sales(5y)31.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20.43%
EPS Next Y44.21%
EPS Next 2Y25.74%
EPS Next 3Y18.94%
EPS Next 5YN/A
Revenue 1Y (TTM)-16.89%
Revenue growth 3Y122.95%
Revenue growth 5Y117.49%
Sales Q2Q%4.5%
Revenue Next Year-13.88%
Revenue Next 2Y4.07%
Revenue Next 3Y6.17%
Revenue Next 5Y5.61%
EBIT growth 1Y12.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year60.4%
EBIT Next 3Y19.97%
EBIT Next 5Y10.15%
FCF growth 1Y109.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y110.27%
OCF growth 3YN/A
OCF growth 5YN/A

XOS INC / XOS Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for XOS INC?

ChartMill assigns a fundamental rating of 3 / 10 to XOS.


Can you provide the valuation status for XOS INC?

ChartMill assigns a valuation rating of 2 / 10 to XOS INC (XOS). This can be considered as Overvalued.


Can you provide the profitability details for XOS INC?

XOS INC (XOS) has a profitability rating of 0 / 10.